Name: | Description: | Size: | Format: | |
---|---|---|---|---|
199.25 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Diagnosis of Alzheimer's disease (AD) confirmed by biomarkers allows the patient to make important life decisions. However, doubt about the fleetness of symptoms progression and future cognitive decline remains. Neuropsychological measures were extensively studied in prediction of time to conversion to dementia for mild cognitive impairment (MCI) patients in the absence of biomarker information. Similar neuropsychological measures might also be useful to predict the progression to dementia in patients with MCI due to AD.
Description
Fundação para a Ciência e Tecnologia
Keywords
Alzheimer’s disease Cognitive impairment Amyloid Dementia Mild cognitive impairment due to AD Neuropsychological assessment Prodromal Raven Coloured Progressive Matrices
Citation
Journal of Alzheimer's Disease, 74(3), 785-796 Doi.:10.3233/JAD-191133
Publisher
IOS Press